• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在结肠 26 荷瘤成年小鼠中建立人类癌症恶病质模型。

Modeling human cancer cachexia in colon 26 tumor-bearing adult mice.

机构信息

Department of Molecular Virology, Immunology, and Medical Genetics, Human Cancer Genetics Program, and the Arthur G. James Comprehensive Cancer Center, The Ohio State University College of Medicine, 460 W. 12th Avenue, Columbus, OH, 43210, USA,

出版信息

J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):321-8. doi: 10.1007/s13539-014-0141-2. Epub 2014 Mar 26.

DOI:10.1007/s13539-014-0141-2
PMID:24668658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4248405/
Abstract

BACKGROUND

Muscle wasting is a profound side effect of advanced cancer. Cancer-induced cachexia decreases patient quality of life and is associated with poor patient survival. Currently, no clinical therapies exist to treat cancer-induced muscle wasting. Although cancers commonly associated with cachexia occur in older individuals, the standard animal models used to elucidate the causes of cachexia rely on juvenile mice.

METHODS

In an effort to better model human cancer cachexia, we determined whether cachectic features seen in young mice could be achieved in adult, pre-sarcopenic mice following colon 26 (C-26) tumor cell inoculation.

RESULTS

Both young and adult mice developed similar-sized tumors and progressed to cachexia with similar kinetics, as evidenced by losses in body mass, and adipose and skeletal muscle tissues. Proteolytic signaling, including proteasome and autophagy genes, was also increased in muscles from both young and adult tumor-bearing animals. Furthermore, tumor-associated muscle damage and activation of Pax7 progenitor cells was induced in both young and adult mice.

CONCLUSIONS

Although cancer cachexia generally occurs in older individuals, these data suggest that the phenotype and underlying mechanisms can be effectively modeled using the currently accepted protocol in juvenile mice.

摘要

背景

肌肉减少症是晚期癌症的一种严重副作用。癌症引起的恶病质会降低患者的生活质量,并与患者预后不良相关。目前,尚无临床疗法可治疗癌症引起的肌肉减少症。尽管与恶病质相关的癌症通常发生在老年人中,但用于阐明恶病质原因的标准动物模型依赖于幼年小鼠。

方法

为了更好地模拟人类癌症恶病质,我们确定了在结肠 26(C-26)肿瘤细胞接种后,年轻小鼠是否可以在成年、有肌肉减少症前期的小鼠中出现恶病质特征。

结果

年轻和成年小鼠均形成了相似大小的肿瘤,并以相似的动力学进展为恶病质,表现为体重、脂肪和骨骼肌组织的丧失。来自年轻和成年荷瘤动物的肌肉中的蛋白水解信号,包括蛋白酶体和自噬基因,也增加了。此外,肿瘤相关的肌肉损伤和 Pax7 祖细胞的激活在年轻和成年小鼠中均被诱导。

结论

尽管癌症恶病质通常发生在老年人中,但这些数据表明,使用目前在幼年小鼠中接受的方案,可以有效地模拟表型和潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/99713f4c17e4/13539_2014_141_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/7abbbb5e85b6/13539_2014_141_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/660834d796d8/13539_2014_141_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/689dc0e769a0/13539_2014_141_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/99713f4c17e4/13539_2014_141_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/7abbbb5e85b6/13539_2014_141_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/660834d796d8/13539_2014_141_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/689dc0e769a0/13539_2014_141_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf3/4248405/99713f4c17e4/13539_2014_141_Fig4_HTML.jpg

相似文献

1
Modeling human cancer cachexia in colon 26 tumor-bearing adult mice.在结肠 26 荷瘤成年小鼠中建立人类癌症恶病质模型。
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):321-8. doi: 10.1007/s13539-014-0141-2. Epub 2014 Mar 26.
2
Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.在癌症恶病质的 C-26 鼠模型的特征描述中,功能和代谢损伤的重要性。
Dis Model Mech. 2012 Jul;5(4):533-45. doi: 10.1242/dmm.008839. Epub 2012 Mar 22.
3
Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.抑制Stat3激活可抑制半胱天冬酶-3和泛素-蛋白酶体系统,从而在癌症恶病质中维持肌肉质量。
J Biol Chem. 2015 Apr 24;290(17):11177-87. doi: 10.1074/jbc.M115.641514. Epub 2015 Mar 18.
4
Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.小鼠模型中早期和晚期癌症恶病质诱导的肌肉萎缩的比较分子分析。
Oncol Rep. 2016 Dec;36(6):3291-3302. doi: 10.3892/or.2016.5165. Epub 2016 Oct 12.
5
Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.隐丹参酮通过抑制 STAT3 信号通路预防 CT26 诱导的癌症恶病质引起的肌肉减少症。
J Ethnopharmacol. 2020 Oct 5;260:113066. doi: 10.1016/j.jep.2020.113066. Epub 2020 Jun 4.
6
Effects of the beta agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia.β 激动剂福莫特罗对癌症恶病质大鼠呼吸肌和肢体肌萎缩信号、自噬和肌肉表型的影响。
Biochimie. 2018 Jun;149:79-91. doi: 10.1016/j.biochi.2018.04.009. Epub 2018 Apr 12.
7
Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.特异性蛋白酶体抑制剂硼替佐米对癌症相关肌肉消耗的影响。
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):345-54. doi: 10.1002/jcsm.12050. Epub 2015 Jul 7.
8
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.NF-κB 介导的肌肉微环境中 Pax7 的失调促进癌症恶病质。
J Clin Invest. 2013 Nov;123(11):4821-35. doi: 10.1172/JCI68523.
9
Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.PARP活性在肺癌所致恶病质中的作用:对肌肉氧化应激、蛋白水解、合成代谢标志物及表型的影响
J Cell Physiol. 2017 Dec;232(12):3744-3761. doi: 10.1002/jcp.25851. Epub 2017 Apr 27.
10
Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.抑制肾素-血管紧张素系统可改善轻度或重度癌性恶病质小鼠的生理结局。
Int J Cancer. 2013 Sep 1;133(5):1234-46. doi: 10.1002/ijc.28128. Epub 2013 Mar 16.

引用本文的文献

1
Modulating the Gut-Muscle Axis: Increasing SCFA-Producing Gut Microbiota Commensals and Decreasing Endotoxin Production to Mitigate Cancer Cachexia.调节肠-肌轴:增加产生短链脂肪酸的肠道微生物共生菌并减少内毒素产生以减轻癌症恶病质。
Microorganisms. 2025 Jun 11;13(6):1356. doi: 10.3390/microorganisms13061356.
2
Regulating Sirtuin 3-mediated mitochondrial dynamics through vanillic acid improves muscle atrophy in cancer-induced cachexia.通过香草酸调节沉默调节蛋白3介导的线粒体动力学可改善癌症诱导的恶病质中的肌肉萎缩。
Commun Biol. 2025 Apr 9;8(1):585. doi: 10.1038/s42003-025-07770-0.
3
Cancer cachexia: multilevel metabolic dysfunction.

本文引用的文献

1
p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice.p38 MAPK 信号通路是导致老年小鼠骨骼肌中干细胞自我更新丧失的细胞自主性机制。
Nat Med. 2014 Mar;20(3):265-71. doi: 10.1038/nm.3465. Epub 2014 Feb 16.
2
Rejuvenation of the muscle stem cell population restores strength to injured aged muscles.肌肉干细胞群体的再生恢复了受伤老年肌肉的力量。
Nat Med. 2014 Mar;20(3):255-64. doi: 10.1038/nm.3464. Epub 2014 Feb 16.
3
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.
癌症恶病质:多级代谢功能障碍。
Nat Metab. 2024 Dec;6(12):2222-2245. doi: 10.1038/s42255-024-01167-9. Epub 2024 Nov 22.
4
Low-dose orthotopic cancer implantation permits measurement of longitudinal functional changes associated with cachexia.低剂量原位癌症植入允许测量与恶病质相关的纵向功能变化。
J Appl Physiol (1985). 2024 Sep 1;137(3):705-717. doi: 10.1152/japplphysiol.00173.2024. Epub 2024 Jul 25.
5
Cancer cachexia: biomarkers and the influence of age.癌症恶病质:生物标志物和年龄的影响。
Mol Oncol. 2024 Sep;18(9):2070-2086. doi: 10.1002/1878-0261.13590. Epub 2024 Feb 27.
6
Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice.白血病抑制因子抑制肝从头脂肪生成并诱导小鼠恶病质。
Nat Commun. 2024 Jan 20;15(1):627. doi: 10.1038/s41467-024-44924-w.
7
Regulation of Satellite Cells Functions during Skeletal Muscle Regeneration: A Critical Step in Physiological and Pathological Conditions.卫星细胞功能在骨骼肌再生中的调控:生理和病理条件下的关键步骤。
Int J Mol Sci. 2023 Dec 29;25(1):512. doi: 10.3390/ijms25010512.
8
Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions.癌症恶病质:潜在机制与可能的治疗干预措施
Metabolites. 2023 Sep 20;13(9):1024. doi: 10.3390/metabo13091024.
9
Tumor loss-of-function mutations in STK11/LKB1 induce cachexia.抑癌基因 STK11/LKB1 的肿瘤功能丧失突变可诱发恶病质。
JCI Insight. 2023 Apr 24;8(8):e165419. doi: 10.1172/jci.insight.165419.
10
Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies.癌症恶病质相关骨骼肌丢失的分子机制:临床前和临床研究数据分析。
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1150-1167. doi: 10.1002/jcsm.13073. Epub 2023 Mar 2.
NF-κB 介导的肌肉微环境中 Pax7 的失调促进癌症恶病质。
J Clin Invest. 2013 Nov;123(11):4821-35. doi: 10.1172/JCI68523.
4
Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models.促红细胞生成素给药部分预防实验性癌症恶病质模型中的脂肪组织丢失。
J Lipid Res. 2013 Nov;54(11):3045-51. doi: 10.1194/jlr.M038406. Epub 2013 Aug 21.
5
Diaphragm and ventilatory dysfunction during cancer cachexia.癌症恶病质期间的膈肌和通气功能障碍。
FASEB J. 2013 Jul;27(7):2600-10. doi: 10.1096/fj.12-222844. Epub 2013 Mar 20.
6
New horizons in the pathogenesis, diagnosis and management of sarcopenia.肌肉减少症发病机制、诊断和治疗的新进展。
Age Ageing. 2013 Mar;42(2):145-50. doi: 10.1093/ageing/afs191. Epub 2013 Jan 11.
7
Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem.癌症恶病质:恶性炎症、肿瘤因子和代谢混乱。
Trends Endocrinol Metab. 2013 Apr;24(4):174-83. doi: 10.1016/j.tem.2012.10.006. Epub 2012 Nov 29.
8
The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli.泛素连接酶 Mul1 响应肌肉消耗性刺激诱导骨骼肌中的自噬。
Cell Metab. 2012 Nov 7;16(5):613-24. doi: 10.1016/j.cmet.2012.10.005.
9
The aged niche disrupts muscle stem cell quiescence.衰老小生境破坏肌肉干细胞静止。
Nature. 2012 Oct 18;490(7420):355-60. doi: 10.1038/nature11438. Epub 2012 Sep 26.
10
Cancer cachexia: mediators, signaling, and metabolic pathways.癌症恶病质:介质、信号和代谢途径。
Cell Metab. 2012 Aug 8;16(2):153-66. doi: 10.1016/j.cmet.2012.06.011. Epub 2012 Jul 12.